A patient of chronic myelogenous leukemia developing painful rash on feet
Hand foot disease (HFD), also known as palmoplantar erythrodysaesthesia (PPE), is a distinctive cutaneous adverse drug reaction to certain chemotherapeutic agents. 5-Fluorouracil by infusion, capecitabine, cytarabine, docetaxel, and doxorubicin are the commonly implicated agents. [1] Here, we are re...
Gespeichert in:
| Veröffentlicht in: | Journal of postgraduate medicine 2012-10, Vol.58 (4), p.331-334 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 334 |
|---|---|
| container_issue | 4 |
| container_start_page | 331 |
| container_title | Journal of postgraduate medicine |
| container_volume | 58 |
| creator | Kumar, P Das, N K Sil, A Chakrabarti, P |
| description | Hand foot disease (HFD), also known as palmoplantar erythrodysaesthesia (PPE), is a distinctive cutaneous adverse drug reaction to certain chemotherapeutic agents. 5-Fluorouracil by infusion, capecitabine, cytarabine, docetaxel, and doxorubicin are the commonly implicated agents. [1] Here, we are reporting a case of PPE in a patient receiving imatinib mesylate. PPE due to imatinib mesylate has been reported rarely; however, PPE due to other tyrosine kinase inhibitors are more common. |
| doi_str_mv | 10.4103/0022-3859.105489 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1284314829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A317634329</galeid><sourcerecordid>A317634329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-49e7720a25e000452778c1c4f671b1ba884e9c8d54f897eb23ad50722d4cf66d3</originalsourceid><addsrcrecordid>eNptkUtPAyEURonR-N67MiSup_KaAZaN8dHExI2uCWUu7ejMUGHGxH8vtVVj0rCAXM4BLh9CF5RMBCX8mhDGCq5KPaGkFErvoWOiJSuYYnw_r3-2j9BJSq-E0KoS_BAdMc600oIeo9kUr-zQQD_g4LFbxtA3Dnef0IYF9GFMuIXxDbrG4ho-cnXV9IusNL0fWxxtWuLQYw8wnKEDb9sE59v5FL3c3T7fPBSPT_ezm-lj4YSgQyE0SMmIZSUQQkTJpFSOOuErSed0bpUSoJ2qS-GVljBn3NYlkYzVwvmqqvkputqcu4rhfYQ0mNcwxj5faShTglOhmP6jFrYFk18bhmhd1yRnppzKigv-TRU7qNw4RNuGHnyTy__4yQ4-jzr_kNspkI3gYkgpgjer2HQ2fhpKzDpCs87IrDMymwizcrntb5x3UP8KP5nxL0jmkug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1284314829</pqid></control><display><type>article</type><title>A patient of chronic myelogenous leukemia developing painful rash on feet</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kumar, P ; Das, N K ; Sil, A ; Chakrabarti, P</creator><creatorcontrib>Kumar, P ; Das, N K ; Sil, A ; Chakrabarti, P</creatorcontrib><description>Hand foot disease (HFD), also known as palmoplantar erythrodysaesthesia (PPE), is a distinctive cutaneous adverse drug reaction to certain chemotherapeutic agents. 5-Fluorouracil by infusion, capecitabine, cytarabine, docetaxel, and doxorubicin are the commonly implicated agents. [1] Here, we are reporting a case of PPE in a patient receiving imatinib mesylate. PPE due to imatinib mesylate has been reported rarely; however, PPE due to other tyrosine kinase inhibitors are more common.</description><identifier>ISSN: 0022-3859</identifier><identifier>EISSN: 0972-2823</identifier><identifier>DOI: 10.4103/0022-3859.105489</identifier><identifier>PMID: 23298941</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Adult ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Benzamides - adverse effects ; Benzamides - therapeutic use ; Case studies ; Chronic myeloid leukemia ; Complications and side effects ; Development and progression ; Diagnosis ; Drug Eruptions - etiology ; Drug Eruptions - pathology ; Drug therapy ; Exanthema - chemically induced ; Exanthema - drug therapy ; Foot diseases ; Hand-Foot Syndrome ; Humans ; Imatinib Mesylate ; Leukemia ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Male ; Palmar-plantar erythrodysesthesia ; Piperazines - adverse effects ; Piperazines - therapeutic use ; Pyrimidines - adverse effects ; Pyrimidines - therapeutic use ; Side effects ; Treatment Outcome</subject><ispartof>Journal of postgraduate medicine, 2012-10, Vol.58 (4), p.331-334</ispartof><rights>COPYRIGHT 2012 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Oct-Dec 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-49e7720a25e000452778c1c4f671b1ba884e9c8d54f897eb23ad50722d4cf66d3</citedby><cites>FETCH-LOGICAL-c441t-49e7720a25e000452778c1c4f671b1ba884e9c8d54f897eb23ad50722d4cf66d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23298941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, P</creatorcontrib><creatorcontrib>Das, N K</creatorcontrib><creatorcontrib>Sil, A</creatorcontrib><creatorcontrib>Chakrabarti, P</creatorcontrib><title>A patient of chronic myelogenous leukemia developing painful rash on feet</title><title>Journal of postgraduate medicine</title><addtitle>J Postgrad Med</addtitle><description>Hand foot disease (HFD), also known as palmoplantar erythrodysaesthesia (PPE), is a distinctive cutaneous adverse drug reaction to certain chemotherapeutic agents. 5-Fluorouracil by infusion, capecitabine, cytarabine, docetaxel, and doxorubicin are the commonly implicated agents. [1] Here, we are reporting a case of PPE in a patient receiving imatinib mesylate. PPE due to imatinib mesylate has been reported rarely; however, PPE due to other tyrosine kinase inhibitors are more common.</description><subject>Adult</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Benzamides - adverse effects</subject><subject>Benzamides - therapeutic use</subject><subject>Case studies</subject><subject>Chronic myeloid leukemia</subject><subject>Complications and side effects</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Drug Eruptions - etiology</subject><subject>Drug Eruptions - pathology</subject><subject>Drug therapy</subject><subject>Exanthema - chemically induced</subject><subject>Exanthema - drug therapy</subject><subject>Foot diseases</subject><subject>Hand-Foot Syndrome</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Leukemia</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Male</subject><subject>Palmar-plantar erythrodysesthesia</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - therapeutic use</subject><subject>Pyrimidines - adverse effects</subject><subject>Pyrimidines - therapeutic use</subject><subject>Side effects</subject><subject>Treatment Outcome</subject><issn>0022-3859</issn><issn>0972-2823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkUtPAyEURonR-N67MiSup_KaAZaN8dHExI2uCWUu7ejMUGHGxH8vtVVj0rCAXM4BLh9CF5RMBCX8mhDGCq5KPaGkFErvoWOiJSuYYnw_r3-2j9BJSq-E0KoS_BAdMc600oIeo9kUr-zQQD_g4LFbxtA3Dnef0IYF9GFMuIXxDbrG4ho-cnXV9IusNL0fWxxtWuLQYw8wnKEDb9sE59v5FL3c3T7fPBSPT_ezm-lj4YSgQyE0SMmIZSUQQkTJpFSOOuErSed0bpUSoJ2qS-GVljBn3NYlkYzVwvmqqvkputqcu4rhfYQ0mNcwxj5faShTglOhmP6jFrYFk18bhmhd1yRnppzKigv-TRU7qNw4RNuGHnyTy__4yQ4-jzr_kNspkI3gYkgpgjer2HQ2fhpKzDpCs87IrDMymwizcrntb5x3UP8KP5nxL0jmkug</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Kumar, P</creator><creator>Das, N K</creator><creator>Sil, A</creator><creator>Chakrabarti, P</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20121001</creationdate><title>A patient of chronic myelogenous leukemia developing painful rash on feet</title><author>Kumar, P ; Das, N K ; Sil, A ; Chakrabarti, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-49e7720a25e000452778c1c4f671b1ba884e9c8d54f897eb23ad50722d4cf66d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Benzamides - adverse effects</topic><topic>Benzamides - therapeutic use</topic><topic>Case studies</topic><topic>Chronic myeloid leukemia</topic><topic>Complications and side effects</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Drug Eruptions - etiology</topic><topic>Drug Eruptions - pathology</topic><topic>Drug therapy</topic><topic>Exanthema - chemically induced</topic><topic>Exanthema - drug therapy</topic><topic>Foot diseases</topic><topic>Hand-Foot Syndrome</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Leukemia</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Male</topic><topic>Palmar-plantar erythrodysesthesia</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - therapeutic use</topic><topic>Pyrimidines - adverse effects</topic><topic>Pyrimidines - therapeutic use</topic><topic>Side effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, P</creatorcontrib><creatorcontrib>Das, N K</creatorcontrib><creatorcontrib>Sil, A</creatorcontrib><creatorcontrib>Chakrabarti, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of postgraduate medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, P</au><au>Das, N K</au><au>Sil, A</au><au>Chakrabarti, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A patient of chronic myelogenous leukemia developing painful rash on feet</atitle><jtitle>Journal of postgraduate medicine</jtitle><addtitle>J Postgrad Med</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>58</volume><issue>4</issue><spage>331</spage><epage>334</epage><pages>331-334</pages><issn>0022-3859</issn><eissn>0972-2823</eissn><abstract>Hand foot disease (HFD), also known as palmoplantar erythrodysaesthesia (PPE), is a distinctive cutaneous adverse drug reaction to certain chemotherapeutic agents. 5-Fluorouracil by infusion, capecitabine, cytarabine, docetaxel, and doxorubicin are the commonly implicated agents. [1] Here, we are reporting a case of PPE in a patient receiving imatinib mesylate. PPE due to imatinib mesylate has been reported rarely; however, PPE due to other tyrosine kinase inhibitors are more common.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>23298941</pmid><doi>10.4103/0022-3859.105489</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-3859 |
| ispartof | Journal of postgraduate medicine, 2012-10, Vol.58 (4), p.331-334 |
| issn | 0022-3859 0972-2823 |
| language | eng |
| recordid | cdi_proquest_journals_1284314829 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adult Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Benzamides - adverse effects Benzamides - therapeutic use Case studies Chronic myeloid leukemia Complications and side effects Development and progression Diagnosis Drug Eruptions - etiology Drug Eruptions - pathology Drug therapy Exanthema - chemically induced Exanthema - drug therapy Foot diseases Hand-Foot Syndrome Humans Imatinib Mesylate Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Palmar-plantar erythrodysesthesia Piperazines - adverse effects Piperazines - therapeutic use Pyrimidines - adverse effects Pyrimidines - therapeutic use Side effects Treatment Outcome |
| title | A patient of chronic myelogenous leukemia developing painful rash on feet |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A34%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20patient%20of%20chronic%20myelogenous%20leukemia%20developing%20painful%20rash%20on%20feet&rft.jtitle=Journal%20of%20postgraduate%20medicine&rft.au=Kumar,%20P&rft.date=2012-10-01&rft.volume=58&rft.issue=4&rft.spage=331&rft.epage=334&rft.pages=331-334&rft.issn=0022-3859&rft.eissn=0972-2823&rft_id=info:doi/10.4103/0022-3859.105489&rft_dat=%3Cgale_proqu%3EA317634329%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1284314829&rft_id=info:pmid/23298941&rft_galeid=A317634329&rfr_iscdi=true |